[1]
Moayedi, J., Hashempour, T., Musavi, Z., Dehghani, B., Hasanshahi, Z. and Merat, S. 2020. The Predictive Factors for Favorable Outcomes of Peginterferon and Ribavirin Combination Therapy in HCV-Infected Patients. Acta Medica Iranica. 58, 5 (Aug. 2020), 214-220. DOI:https://doi.org/10.18502/acta.v58i5.3954.